1. Home
  2. PROK vs ONIT Comparison

PROK vs ONIT Comparison

Compare PROK & ONIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • ONIT
  • Stock Information
  • Founded
  • PROK 2015
  • ONIT 1988
  • Country
  • PROK United States
  • ONIT United States
  • Employees
  • PROK N/A
  • ONIT N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • ONIT
  • Sector
  • PROK Health Care
  • ONIT
  • Exchange
  • PROK Nasdaq
  • ONIT NYSE
  • Market Cap
  • PROK 85.5M
  • ONIT 308.3M
  • IPO Year
  • PROK N/A
  • ONIT 1996
  • Fundamental
  • Price
  • PROK $0.64
  • ONIT $38.67
  • Analyst Decision
  • PROK Hold
  • ONIT Strong Buy
  • Analyst Count
  • PROK 3
  • ONIT 2
  • Target Price
  • PROK $3.50
  • ONIT $52.50
  • AVG Volume (30 Days)
  • PROK 1.7M
  • ONIT 38.7K
  • Earning Date
  • PROK 08-08-2025
  • ONIT 07-31-2025
  • Dividend Yield
  • PROK N/A
  • ONIT N/A
  • EPS Growth
  • PROK N/A
  • ONIT 248.50
  • EPS
  • PROK N/A
  • ONIT 2.98
  • Revenue
  • PROK $306,000.00
  • ONIT $986,700,000.00
  • Revenue This Year
  • PROK $54.34
  • ONIT $7.68
  • Revenue Next Year
  • PROK N/A
  • ONIT $9.23
  • P/E Ratio
  • PROK N/A
  • ONIT $12.97
  • Revenue Growth
  • PROK N/A
  • ONIT N/A
  • 52 Week Low
  • PROK $0.46
  • ONIT $22.40
  • 52 Week High
  • PROK $2.59
  • ONIT $41.27
  • Technical
  • Relative Strength Index (RSI)
  • PROK 43.63
  • ONIT 58.69
  • Support Level
  • PROK $0.54
  • ONIT $37.20
  • Resistance Level
  • PROK $0.90
  • ONIT $37.99
  • Average True Range (ATR)
  • PROK 0.13
  • ONIT 1.22
  • MACD
  • PROK -0.02
  • ONIT 0.06
  • Stochastic Oscillator
  • PROK 20.25
  • ONIT 84.26

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About ONIT ONITY GROUP INC

Onity Group Inc is a non-bank mortgage servicer and originator providing solutions through its brands, PHH Mortgage and Liberty Reverse Mortgage. PHH Mortgage is one of the servicers in the country, focused on delivering a variety of servicing and lending programs. Liberty is one of the nation's reverse mortgage lenders dedicated to education and providing loans that help customers meet their personal and financial needs.

Share on Social Networks: